|
|
 |
|
Viewing report
|
|
|
|
Rheumatoid Arthritis Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., Feb 2010, Pages: 824
This report analyzes the worldwide markets for Rheumatoid Arthritis Therapeutics in US$ Million.
The report provides separate comprehensive analytics for US, Japan, Europe, Latin America and Rest of World.
Annual forecasts are provided for each region for the period 2006 through 2015.
The report profiles 103 companies including many key and niche players worldwide such as
- Abbott Laboratories, Inc.
- Amgen, Inc.
- Biogen Idec, Inc
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- Chugai Pharmaceutical Co., Ltd.
- Genentech Inc.
- Genmab AS
- GlaxoSmithKline PLC
- Johnson & Johnson Services, Inc.
- Schering-Plough Corp.
- UCB S.A.
- Wyeth.
Market data and analytics are derived from primary and secondary research.
Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Special Report: The Autoimmune Biologics Pipeline-A Competitive Review
Product Profiles: Disease Modification in Rheumatoid Arthritis - Game-changing therapy close to market
Anti-CD20 Monoclonal Antibodies - Global Strategic Business Report
The Rheumatoid Arthritis Market - Competitive Landscape and Clinical Stage Analysis
Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success
Prescription Drugs - Global Strategic Business Report
Angiogenesis Inhibitors and Stimulators - Global Strategic Business Report
Rheumatoid Arthritis Drug Discoveries: what the future holds
Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic Arthritis
Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
|
|
|
|
